Gregory Belinfanti Adds to AdaptHealth Corp. Holdings
Gregory Belinfanti purchased 18,999 shares of AdaptHealth Corp. on June 24, 2026.
Key Points
- Gregory Belinfanti bought 18,999 shares of AdaptHealth Corp. on June 24, 2026, enhancing his stake in the company.
- Shares of AdaptHealth Corp. traded at $10.18 on Saturday, with a market cap of approximately $1.4 billion.
- Analysts from RBC Capital and Canaccord Genuity maintain a 'buy' rating with targets of $15 and $16, respectively.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Gregory Belinfanti made a move on June 24, 2026, by buying 18,999 shares of AdaptHealth Corp. (NasdaqCM: AHCO). This purchase adds to his holdings in the company, reflecting continued interest in the healthcare sector.
Insider Buying and Selling at AdaptHealth Corp.
On June 24, 2026, several insiders, including Gregory Belinfanti, acquired 18,999 shares each of AdaptHealth Corp. This buying activity was not part of a pre-planned trading program, indicating a spontaneous decision to invest more in the company.
AdaptHealth Corp. Stock Up 77.7%
Shares of AdaptHealth Corp. traded near $10.18 on Saturday. The company, with a market cap of about $1.4 billion, operates in the medical devices industry. It has a forward P/E ratio of 8.8 and a beta of 1.463, suggesting a higher volatility compared to the market. The stock's 52-week range has seen lows of $8.51 and highs of $13.43, with moving averages of $10.99 over 50 days and $10.21 over 200 days.
$AHCO stock price
Daily closing prices, year to date. Not investment advice.
Analysts Set New Price Targets
Analysts remain optimistic about AdaptHealth Corp.'s prospects. On May 11, 2026, RBC Capital maintained its 'buy' rating and set a price target of $15. Similarly, Canaccord Genuity reaffirmed its 'buy' rating with a target of $16 on May 6, 2026. The consensus among eight analysts is a 'buy' recommendation, with a mean price target of $14.
About AdaptHealth Corp.
AdaptHealth Corp. is a healthcare company based in Conshohocken, Pennsylvania. It provides home medical equipment and related services across the United States. The company serves patients with sleep apnea, diabetes, and other chronic conditions through various segments, including Sleep Health and Respiratory Health. It was founded in 2012 and is led by CEO Ms. Suzanne M. Foster.
Bottom Line
Gregory Belinfanti's recent purchase of AdaptHealth Corp. shares highlights ongoing insider interest in the company. With a solid market position and analyst support, AdaptHealth is a company to watch. However, as with all 13F filings, this insider activity reflects past actions and may not indicate future intentions.
Get AdaptHealth Corp. alerts
New 13F filings, insider trades, and analyst moves on $AHCO, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.